Hepatitis Clinical Trials

Showing 321-340 of 1,007 trials

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

NCT00100581

A significant proportion of HIV infected people in the U.S. are also infected with hepatitis C virus (HCV). The purpose of this study is to determine the effects of anti-HIV therapy on treatment of HCV with pegylated interferon alfa-2a and ribavirin (PEG/RBV).

HIV InfectionsHepatitis C

National Institute of Allergy and Infectious Diseases (NIAID)2 participants

New York, New York, United States • Dallas, Texas, United States

COMPLETEDPHASE2/PHASE3

Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis

NCT01809132

This study will compare two different treatments of acute alcoholic hepatitis. The current standard of care is treatment with corticosteroids (methylprednisolone). This will be compared to treatment with anakinra, pentoxifylline, plus zinc sulfate. The participants will be treated and followed for 6 months and the two treatment groups will be compared for differences in death rates and laboratory tests that measure liver and gut function.

Acute Alcoholic Hepatitis

Mack Mitchell104 participantsStarted Sep 2013

Louisville, Kentucky, United States • Worcester, Massachusetts, United States • Cleveland, Ohio, United States +1 more locations

COMPLETEDPHASE2

Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection

NCT01587586

Primary objectives: The purpose of this study is to determine and compare the sustained virologic response (SVR, undetectable HCV RNA at Follow up week 24 (FW24)) across treatment groups. To determine and compare the safety and tolerability of P1101 + Ribavirin across treatment groups.

Hepatitis C, Chronic

PharmaEssentia107 participantsStarted Oct 2011

Changhua, Taiwan • Douliu, Taiwan • Kaohsiung City, Taiwan +10 more locations

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis

Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection

Related Searches

Reaching mEthadone Users Attending Community pHarmacies With HCV

A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of SNP-630 in Health Subjects.

Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World

Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity

Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients

A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret

Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen

HCV Reinfection After DAA Therapy in PWID in Belgium

Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism

Improving Inpatient Screening for Hepatitis C

Puglia HCV Micro-elimination Program

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection

Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients

Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine

Truenat™ HCV RNA Assay Evaluation

Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV

Access Anti-HCV Assay European Union (EU) Clinical Trial Protocol